scispace - formally typeset
M

Michael T. Zimmermann

Researcher at Medical College of Wisconsin

Publications -  129
Citations -  3540

Michael T. Zimmermann is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Exome sequencing & Exome. The author has an hindex of 25, co-authored 124 publications receiving 2610 citations. Previous affiliations of Michael T. Zimmermann include Iowa State University & Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Crystal structures of the CusA efflux pump suggest methionine-mediated metal transport

TL;DR: The crystal structure indicates that CusA has, in addition to the three-methionine metal-binding site, four methionine pairs—three located in the transmembrane region and one in the periplasmic domain, which directly suggests a plausible pathway for ion export.
Journal ArticleDOI

Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma.

TL;DR: The volume of hematoma in the basal cisterns as detected by computerized tomography was predictive of the concentrations of ETs in the CSF, and the temporal dependence of concentrations of big ET-1 andET-1 in SAH patients with and without CVS were significantly different.
Journal ArticleDOI

Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli

TL;DR: The co-crystal structure of the CusBA efflux complex is reported, showing that the transporter (or pump) CusA, which is present as a trimer, interacts with six CusB protomers and that the periplasmic domain of CUSA is involved in these interactions.
Journal ArticleDOI

Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage

TL;DR: In poor-grade patients, moderate hypertension in a normovolemic, hemodiluted patient is an effective method of improving cerebral oxygenation and is associated with a lower complication rate compared with hypervolemia or aggressive hypertension therapy.